Publications
Selected Publications:
Szlachta K, Manukyan A, Raimer, H, Singh S, Salamon A, Guo W, Lobachev K, Wang YH. Topoisomerase II contributes to DNA secondary structure-mediated double-stranded breaks. Nucleic Acids Research. 2020; 48(12):6654-6671. PMID: 32501506.
Singh S, Szlachta K, Manukyan A, Raimer H, Dinda M, Bekiranov S, Wang YH. Pausing sites of RNA polymerase II on actively transcribed genes are enriched with DNA double-stranded breaks. JBC. 2020; 295(12):3990-4000. PMID: 32029477
Szlachta K, Raimer H, Comeau L, Wang YH. CNCC: An analysis tool to determine genome-wide DNA break end structure at single-nucleotide resolution. BMC Genomics. 2020; 21(1):25. PMID: 31914926.
Irony-Tur Sinai M, Salamon A, Stanleigh N, Goldberg T, Weiss A, Wang YH, Kerem B, AT-dinucleotide rich sequences drive fragile site formation., 2019; Nucleic Acids Research. 47(18) 9685-9695. PMID: 31410468
Atkin N, Raimer H, Wang YH. Broken by the Cut: A Journey into the Role of Topoisomerase II on DNA Fragility. Genes. 2019; 10(10):791. PMID:31614754.
Huckaby AC, Granum CS, Carey MA, Szlachta K, Al-Barghouthi B, Wang YH, Guler JL, Complex DNA structures trigger copy number variation across the Plasmodium falciparum genome., 2018; Nucleic Acids Research. 47(4) 1615-1627. PMID: 30576466
Szlachta K, Thys R, Atkin N, Pierce L, Bekiranov S, Wang YH. Alternative DNA secondary structure formation affects RNA polymerase II promoter-proximal pausing in human. Genome Biology. 2018; 19(1):89. PMID:30001206.
Lehman C, Dillon L, Nikiforov Y, Wang YH. DNA fragile site breakage as a measure of chemical exposure and predictor of individual susceptibility to form oncogenic rearrangements. Carcinogenesis. 2017; 38(3): 293-301. PMID: 28069693
Chen C, Tsao N, Huang L, Yen Y, Liu X, Lehman C, Wang YH, Tseng M, Chen Y, Ho Y, Chen C, Chang Z. The Impact of dUTPase on Ribonucleotide Reductase-Induced Genome Instability in Cancer Cells. Cell reports. 2016; 16(5): 1287-99. PMID: 27452458
Thys R, Lehman C, Pierce L, Wang YH. DNA secondary structure at chromosomal fragile sites in human disease. Current genomics. 2015; 16(1): 60-70. PMID: 25937814 | PMCID: PMC4412965
Thys R, Lehman C, Pierce L, Wang YH. Environmental and chemotherapeutic agents induce breakage at genes involved in leukemia-causing gene rearrangements in human hematopoietic stem/progenitor cells. Mutation research. 2015; 779 86-95. PMID: 26163765
Thys R, Wang Y. DNA Replication Dynamics of the GGGGCC Repeat of the C9orf72 Gene. The Journal of biological chemistry. 2015; 290(48): 28953-62. PMID: 26463209 | PMCID: PMC4661408
Reddy K, Schmidt M, Geist J, Thakkar N, Panigrahi G, Wang Y, Pearson C. Processing of double-R-loops in (CAG)·(CTG) and C9orf72 (GGGGCC)·(GGCCCC) repeats causes instability. Nucleic acids research. 2014; 42(16): 10473-87. PMID: 25147206
Axford M, Wang YH, Nakamori M, Zannis-Hadjopoulos M, Thornton C, Pearson C. Detection of Slipped-DNAs at the Trinucleotide Repeats of the Myotonic Dystrophy Type I Disease Locus in Patient Tissues. PLoS genetics. 2013; 9(12): e1003866. PMID: 24367268 | PMCID: PMC3868534
Dillon L, Pierce L, Lehman C, Nikiforov Y, Wang YH. DNA topoisomerases participate in fragility of the oncogene RET. PloS one. 2013; 8(9): e75741. PMID: 24040417 | PMCID: PMC3770543
Dillon L, Pierce L, Ng M, Wang YH. Role of DNA secondary structures in fragile site breakage along human chromosome 10. Human molecular genetics. 2013; 22(7): 1443-56. PMID: 23297364 | PMCID: PMC3596854
Dillon L, Lehman C, Wang YH. The role of fragile sites in sporadic papillary thyroid carcinoma. Journal of thyroid research. 2012; 2012 927683. PMID: 22762011 | PMCID: PMC3384961
Dillon L, Burrow A, Wang YH. DNA instability at chromosomal fragile sites in cancer. Current genomics. 2011; 11(5): 326-37. PMID: 21286310 | PMCID: PMC2944998
Burrow A, Marullo A, Holder L, Wang YH. Secondary structure formation and DNA instability at fragile site FRA16B. Nucleic acids research. 2010; 38(9): 2865-77. PMID: 20071743 | PMCID: PMC2875025
Gandhi M, Dillon L, Pramanik S, Nikiforov Y, Wang YH. DNA breaks at fragile sites generate oncogenic RET/PTC rearrangements in human thyroid cells. Oncogene. 2010; 29(15): 2272-80. PMID: 20101222 | PMCID: PMC2855398
Wan C, Kulkarni A, Wang YH. ATR preferentially interacts with common fragile site FRA3B and the binding requires its kinase activity in response to aphidicolin treatment. Mutation research. 2010; 686(1): 39-46. PMID: 20060399 | PMCID: PMC2834799
Burrow A, Williams L, Pierce L, Wang YH. Over half of breakpoints in gene pairs involved in cancer-specific recurrent translocations are mapped to human chromosomal fragile sites. BMC genomics. 2009; 10 59. PMID: 19183484 | PMCID: PMC2642838